These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24841498)

  • 1. Acute dysthyroid optic neuropathy exacerbated by orbital radiotherapy.
    Hersh D; Kinnar M
    Orbit; 2014 Oct; 33(5):385-7. PubMed ID: 24841498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete recovery of visual acuity as the main goal of treatment in patients with dysthyroid optic neuropathy.
    Miśkiewicz P; Rutkowska B; Jabłońska A; Krzeski A; Trautsolt-Jeziorska K; Kęcik D; Milczarek-Banach J; Pirko-Kotela K; Samsel A; Bednarczuk T
    Endokrynol Pol; 2016; 67(2):166-73. PubMed ID: 26884288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective endoscopic decompression of the orbital apex for dysthyroid optic neuropathy.
    Chu EA; Miller NR; Lane AP
    Laryngoscope; 2009 Jun; 119(6):1236-40. PubMed ID: 19418538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy.
    Kemchoknatee P; Tangon D; Srisombut T
    BMC Ophthalmol; 2023 Jan; 23(1):32. PubMed ID: 36690985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urgent endoscopic orbital decompression for vision deterioration in dysthyroid optic neuropathy.
    Sowerby LJ; Rajakumar C; Allen L; Rotenberg BW
    Eur Ann Otorhinolaryngol Head Neck Dis; 2019 Jun; 136(3S):S49-S52. PubMed ID: 30170970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysthyroid Optic Neuropathy.
    Saeed P; Tavakoli Rad S; Bisschop PHLT
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S60-S67. PubMed ID: 29927882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of transethmoidal orbital decompression in patients with dysthyroid optic neuropathy].
    Grusha YO; Kochetkov PA; Ismailova DS; Svistushkin VM; Zhorzholadze NV; Spychak VY
    Vestn Otorinolaringol; 2020; 85(6):52-55. PubMed ID: 33474918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysthyroid optic neuropathy: a case series at a tertiary ophthalmic referral centre.
    Chung IY; Hardy TG; Khong JJ
    Eye (Lond); 2024 Apr; 38(6):1168-1172. PubMed ID: 38081935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic outcomes and influence factors of maximal orbital decompression in the treatment of severe dysthyroid optic neuropathy].
    Wang Y; Li YY; Yang N; Ma R; Xiao LH
    Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):416-423. PubMed ID: 28606262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital radiotherapy plus three-wall orbital decompression in a patient with rare ocular manifestations of thyroid eye disease: case report.
    Zhang S; Wang Y; Zhong S; Liu X; Huang Y; Fang S; Zhuang A; Li Y; Sun J; Zhou H; Fan X
    BMC Endocr Disord; 2018 Feb; 18(1):7. PubMed ID: 29409479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of patients with dysthyroid optic neuropathy treated with intravenous corticosteroids and/or orbital decompression surgery.
    Rezar-Dreindl S; Papp A; Baumann A; Neumayer T; Eibenberger K; Stifter E; Schmidt-Erfurth U
    Graefes Arch Clin Exp Ophthalmol; 2022 Nov; 260(11):3683-3691. PubMed ID: 35731314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics of dysthyroid optic neuropathy].
    Elyashiv S; Skaat A; Ben Simon G; Huna-Baron R
    Harefuah; 2015 Feb; 154(2):98-102, 137. PubMed ID: 25856861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative clinical factors and visual outcomes following orbital decompression with dysthyroid optic neuropathy.
    Tagami M; Honda S; Azumi A
    BMC Ophthalmol; 2020 Jan; 20(1):30. PubMed ID: 31952487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of surgical effect in active and inactive Dysthyroid Optic Neuropathy after Endoscopic Transnasal Medial Orbital Decompression.
    Lv X; Gao Y; Ma Y; Li C; Ren Y; Zhang Z; Bao Y; Su S; Lu R
    Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):281-293. PubMed ID: 37530848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure lowering effect of orbital decompression is related to increased venous outflow in Graves orbitopathy.
    Onaran Z; Konuk O; Oktar SÖ; Yücel C; Unal M
    Curr Eye Res; 2014 Jul; 39(7):666-72. PubMed ID: 24502333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysthyroid optic neuropathy: evaluation and management.
    Dolman PJ
    J Endocrinol Invest; 2021 Mar; 44(3):421-429. PubMed ID: 32729049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented endoscopic orbital apex decompression in dysthyroid optic neuropathy.
    Singh S; Curragh DS; Selva D
    Eye (Lond); 2019 Oct; 33(10):1613-1618. PubMed ID: 31068660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysthyroid optic neuropathy: emerging treatment strategies.
    Pelewicz-Sowa M; Miśkiewicz P
    J Endocrinol Invest; 2023 Jul; 46(7):1305-1316. PubMed ID: 36802028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
    McKeag D; Lane C; Lazarus JH; Baldeschi L; Boboridis K; Dickinson AJ; Hullo AI; Kahaly G; Krassas G; Marcocci C; Marinò M; Mourits MP; Nardi M; Neoh C; Orgiazzi J; Perros P; Pinchera A; Pitz S; Prummel MF; Sartini MS; Wiersinga WM;
    Br J Ophthalmol; 2007 Apr; 91(4):455-8. PubMed ID: 17035276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
    Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
    Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.